These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34960125)

  • 21. Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers.
    Jantarabenjakul W; Sodsai P; Chantasrisawad N; Jitsatja A; Ninwattana S; Thippamom N; Ruenjaiman V; Tan CW; Pradit R; Sophonphan J; Wacharapluesadee S; Wang LF; Puthanakit T; Hirankarn N; Putcharoen O
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse Effects on Work and Daily Life Interference among Healthcare Workers after the First and Second ChAdOx1 and BNT162b2 COVID-19 Vaccine Doses.
    Park C; Sakong J; Jo S; Kim M; Baek K
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination.
    Bauswein M; Peterhoff D; Plentz A; Hiergeist A; Wagner R; Gessner A; Salzberger B; Schmidt B; Bauernfeind S
    iScience; 2022 Feb; 25(2):103694. PubMed ID: 35013723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination.
    Lim SY; Kim JY; Park S; Kwon JS; Park JY; Cha HH; Suh MH; Lee HJ; Lim JS; Bae S; Jung J; Lee N; Kim K; Shum D; Jee Y; Kim SH
    Immune Netw; 2021 Dec; 21(6):e41. PubMed ID: 35036028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people.
    Parry H; Bruton R; Stephens C; Brown K; Amirthalingam G; Otter A; Hallis B; Zuo J; Moss P
    Immun Ageing; 2021 Aug; 18(1):34. PubMed ID: 34416887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals.
    Hwang JY; Kim Y; Lee KM; Jang EJ; Woo CH; Hong CU; Choi ST; Xayaheuang S; Jang JG; Ahn JH; Park H
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse reactions and production of neutralizing anti-SARS-CoV-2 antibodies after ChAdOx1 COVID-19 vaccination: A cross-sectional study in a single center.
    Jeong YJ; Kim YJ; Kim SH; Yoo J; Lee J; Lee S; Il Kim S
    J Infect Public Health; 2022 Mar; 15(3):360-364. PubMed ID: 35193817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal Study.
    Kim JA; Bang HI; Shin JW; Park Y; Kim S; Kim MY; Jang EY; Shin WY; Kim J; Park R; Choi TY
    Ann Lab Med; 2022 Nov; 42(6):688-692. PubMed ID: 35765878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination.
    Barocci S; Orlandi C; Diotallevi A; Buffi G; Ceccarelli M; Vandini D; Carlotti E; Galluzzi L; Rocchi MBL; Magnani M; Casabianca A
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impacts of Side Effects to BNT162b2 and the First Dose of ChAdOx1 Anti-SARS-CoV-2 Vaccination on Work Productivity, the Need for Medical Attention, and Vaccine Acceptance: A Multicenter Survey on Healthcare Workers in Referral Teaching Hospitals in the Republic of Korea.
    Kim T; Park SY; Yu S; Park JW; Lee E; Jeon MH; Kim TH; Choo EJ
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34198562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients.
    Lim SY; Yoon YI; Kim JY; Tak E; Song GW; Kim SH; Lee SG
    Immune Netw; 2022 Jun; 22(3):e24. PubMed ID: 35799703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Vicenti I; Basso M; Gatti F; Scaggiante R; Boccuto A; Zago D; Modolo E; Dragoni F; Parisi SG; Zazzi M
    Int J Infect Dis; 2021 Nov; 112():40-44. PubMed ID: 34481967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers.
    Kale P; Gupta E; Bihari C; Patel N; Rooge S; Pandey A; Bajpai M; Khillan V; Chattopadhyay P; Devi P; Maurya R; Jha N; Mehta P; Kumar M; Sharma P; Saifi S; Swaminathan A; Alam S; Uppili B; Faruq M; Agrawal A; Pandey R; Sarin SK
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.
    Joy M; Agrawal U; Fan X; Robertson C; Anand SN; Ordonez-Mena J; Byford R; Goudie R; Jamie G; Kar D; Williams J; Marsden GL; Tzortziou-Brown V; Sheikh SA; Hobbs FDR; de Lusignan S
    Lancet Reg Health Eur; 2023 Sep; 32():100681. PubMed ID: 37671127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain.
    Lechosa-Muñiz C; Paz-Zulueta M; Mendez-Legaza JM; Irure-Ventura J; Cuesta González R; Calvo Montes J; López-Hoyos M; Llorca J; Cabero-Pérez MJ
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova.
    Mason P; Rizzuto R; Iannelli L; Baccaglini F; Rizzolo V; Baraldo A; Melloni B; Maffione F; Pezzoli C; Chiozza ML; Rupolo G; Biasioli M; Liviero F; Scapellato ML; Trevisan A; Merigliano S; Scuttari A; Moretto A; Scarpa B
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243055
    [No Abstract]   [Full Text] [Related]  

  • 39. Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
    Marking U; Havervall S; Greilert-Norin N; Ng H; Blom K; Nilsson P; Phillipson M; Hober S; Nilsson C; Mangsbo S; Christ W; Klingström J; Gordon M; Åberg M; Thålin C
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers.
    Ko GY; Lee J; Bae H; Ryu JH; Park HS; Kang H; Jung J; Choi AR; Lee R; Lee DG; Oh EJ
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37897015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.